Dimerix (ASX:DXB) Accounts Payable : A$0.98 Mil (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is Dimerix Accounts Payable?

Dimerix's Accounts Payable for the quarter that ended in Dec. 2023 was A$0.98 Mil.

Dimerix's quarterly Accounts Payable increased from Dec. 2022 (A$1.31 Mil) to Jun. 2023 (A$5.14 Mil) but then declined from Jun. 2023 (A$5.14 Mil) to Dec. 2023 (A$0.98 Mil).

Dimerix's annual Accounts Payable declined from Jun. 2021 (A$2.52 Mil) to Jun. 2022 (A$1.11 Mil) but then increased from Jun. 2022 (A$1.11 Mil) to Jun. 2023 (A$5.14 Mil).

Dimerix Accounts Payable Historical Data

The historical data trend for Dimerix's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dimerix Accounts Payable Chart

Dimerix Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Accounts Payable

Get a 7-Day Free Trial

0.42

1.15

2.52

1.11

5.14

Dimerix Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable	Get a 7-Day Free Trial															2.01	1.11	1.31	5.14	0.98

Dimerix Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Dimerix Accounts Payable Related Terms

Thank you for viewing the detailed overview of Dimerix's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Dimerix (ASX:DXB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dimerix Ltd (ASX:DXB) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

425 Smith Street, Fitzroy, VIC, AUS, 3065

Website

https://www.dimerix.com

Dimerix Ltd is a biopharmaceutical company developing innovative new therapies in areas with unmet medical needs. The company is developing five product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for COVID-19 pneumonia patients in ICU; DMX-200 for respiratory complications in Covid-19 patients; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.

Dimerix (ASX:DXB) Headlines

No Headlines